Trial · NCT06359782
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of participants with delayed cerebral ischemia (DCI) | To be determined between day 4 and day 14 of admission | Defined as either a new focal neurological impairment, or a decrease of at least 2 points on the Glasgow Coma Scale. This should last for at least 1 hour, is not apparent immediately after aneurysm occlusion, and cannot be attributed to other causes by means of clinical assessment, CT or MRI scanning of the brain, and appropriate laboratory studies. |
| Primary | Number of participants with complications during hospitalization. | Up to 1 year after admission | Complication rate during hospitalization |
| Secondary | Number of participants with cerebral infarction on brain CT | at 14 days after admission | |
| Secondary | Number of participants dying | Up to 1 year after admission | Mortality rate |
| Secondary | Neurological condition measured by Glasgow Coma Scale | During the first 14 days | Measured daily, minimum value of 3, maximal value of 15, higher scores mean a better outcome |
| Secondary | Complement activity markers measured in serum and CSF | Before IV administration of C1-INH or placebo, and after 48 hours and 96 hours after IV administration | WIESLAB, C3b/C, C4b/C, C5b-9 ELISA assays, CH50/AC50 |
| Secondary | Inflammatory markers measured in serum and CSF | Before IV administration of C1-INH or placebo, and after 48 hours and 96 hours after IV administration | TNF-alpha, intraleukins |
| Secondary | Number of days in the hospital | Up to 1 year | Hospital length of stay |
| Secondary | Number of ICU days | Up to 1 year | ICU length of stay |
| Secondary | Number of ventilator days | Up to 1 year | Ventilator days |
| Secondary | Clinical outcome | At 6 months | Modified Ranking Scale, minimum value 0, maximum value 6, higher score means worse outcome |
| Secondary | Clinical outcome | At 6 months | Glasgow Outcome Scale Extended, minimum value 1, maximum value 8, higher score means better outcome |
| Secondary | Clinical outcome | At 6 months | Barthel Index, minimum value 0, maximum value 100, higher score means better outcome |
| Secondary | Clinical outcome | At 6 months | Montreal Cognitive assessment, minimum value 0, maximum value 30, higher score means better outcome |
| Secondary | Clinical outcome | At 6 months | Quality of Life (EQ-5D-5l), minimum value -0.51, maximum value 1, higher score means better outcome |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06359782/registered